Searched for
FENOFIBRATE
Drug used to reduce blood fats may cut SARS-CoV-2 infection by 70 per cent: StudyThe team led by researchers from the University of Birmingham in the UK found that fenofibrate and its active form fenofibric acid can sign...06 Aug, 2021, 12.45 PM IST- Alembic Pharma gets USFDA nod for cholesterol lowering drugIn a regulatory filing, Alembic Pharma said "it has received final approval from the US Food and Drug Administration (USFDA) for its abbrev...21 Oct, 2020, 12.05 PM IST
- Dr Reddy's launches generic lipid-regulating tablets in USPharma major Dr Reddy's Laboratories on Monday said it has launched generic lipid-regulating tablets in the US market.27 Apr, 2020, 01.31 PM IST
- Alembic Pharma's cholesterol drug gets US FDA nodThe approved product is therapeutically equivalent to the reference listed drug product Trilipix Delayed-Release capsules of Abbvie Inc.15 May, 2017, 12.12 PM IST
- Aurobindo Pharma gets final USFDA nod for cholesterol drug"The company has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Fenofibrate Tablets, 48 m...06 May, 2016, 12.45 PM IST
- Ranbaxy Laboratories gets USFDA nod to sell cholesterol medicineRanbaxy received approval from USFDA to manufacture & market Fenofibrate capsules used for lowering high cholesterol & triglyceride levels ...05 Nov, 2014, 06.59 PM IST
- Dr. Reddy's Laboratories launches lipid controlling drug in USA marketThe drug which is indicated to reduce cholesterol and triglycerides (fatty acids) in the blood was approved by the United States Food & Dru...23 Apr, 2014, 04.39 PM IST
- Lupin launches generic Fenofibric Acid capsules in US marketLupin said its US arm has launched generic Fenofibric Acid capsules used for reducing cholesterol and fatty acids in the blood in the Ameri...06 Dec, 2013, 02.18 PM IST
- Lupin gets USFDA nod for additional strengths of cholesterol drug"Lupin Pharmaceuticals Inc (LPI), the company's US subsidiary would commence marketing the product shortly," Lupin said.22 Oct, 2013, 03.20 PM IST
- Lupin falls nearly 5% on Mylan drug launch, Credit Suisse downgradeCredit Suisse downgraded Lupin from ‘outperform’ to ‘neutral’ rating and upped the price target from Rs 710 earlier to Rs 755.20 May, 2013, 11.07 AM IST
- Lupin launches generic Tricor in the USLupin has launched generic version of Tricor in the US market after getting approval from the US Food and Drug Administration.26 Nov, 2012, 05.03 PM IST
- Lupin gets USFDA nod for generic cholesterol drugThe US health regulator has granted approval to Lupin to market generic Fenofibrate Tablets, a cholesterol lowering drug, in the American m...29 Dec, 2011, 07.39 PM IST
- Lupin files second suit against RanbaxyMumbai-based drugmaker Lupin has filed a second suit in the US against Ranbaxy Laboratories to prevent the country’s largest drugmaker from...06 Apr, 2011, 05.02 AM IST
- Abbott, Ranbaxy settle patent suitThe financial upside for Ranbaxy will depend on several factors since there are 3 other drugmakers wanting to launch their versions of the ...19 Feb, 2011, 01.22 AM IST
- Lupin drags Ranbaxy to US court over patent violationPharma major Lupin Ltd has filed a legal suit against rival Ranbaxy in the US, alleging patent violation of its cholesterol-lowering drug, ...09 Aug, 2010, 10.26 PM IST
- Citigroup maintains 'Buy' rating on LupinCitigroup maintains 'Buy' rating on Lupin and raises the target price to Rs 1,415, as they raise EPS estimates (FY10E/11E up 1%/14%) and ro...05 Oct, 2009, 08.00 AM IST
- Citi maintains 'buy' on LupinCiti has maintained its 'buy' rating on mid-sized Indian pharma firm Lupin, and raised its target price to Rs 1,415, following the acquisit...03 Oct, 2009, 03.30 AM IST
Load More
